Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1 9Phase 3 8Phase NA 5Phase EARLY_PHASE1 5Phase 1/2 4

Status

Unknown 5Completed 5Active not recruiting 5Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 21Genitourinary 15Gastrointestinal 15Sarcoma 9Lymphoid 9Head & Neck 9Gynecologic 8Endocrine 8Breast 7Plasma cell 6Other solid neoplasm 5NET 5Thoracic 4Dermatologic 3Tumor-Agnostic 2Other hematologic neoplasm 2

Conditions

Neuroendocrine Tumors 4Recurrence 1Neuroendocrine Tumor Grade 2 1Adenoma, Islet Cell 1

Interventions

lutetium Lu 177 dotatate 1Single Photon Emission Computed Tomography Computed Tomography 190Y-octreotide, DOTA-Tyr(3)- 168Ga-pentixafor 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Active not recruiting × NET × Clear all
NCT04544098 2026-05-07

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT06148636 2025-11-04

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
24 enrolled
EndocrineNET

Adenoma, Islet Cell, Recurrence, Neuroendocrine Tumors

NCT03335670 2025-07-14

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05111509 2025-07-14

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumor Grade 2

NCT03044977 2023-08-16

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡